{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:51:56Z","timestamp":1793404316741,"version":"4.5.0"},"reference-count":234,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.survophthal.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T04:00:21Z","timestamp":1511150421000},"page":"518-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Ophthalmic manifestations in neurofibromatosis type 1"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-8116","authenticated-orcid":false,"given":"Michael","family":"Kinori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickisa","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Lasky","family":"Zeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib1","first-page":"172","article-title":"National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.survophthal.2017.10.007_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2415-14-146","article-title":"Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1","volume":"14","author":"Abdolrahimzadeh","year":"2014","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/IAE.0000000000000650","article-title":"Spectral domain optical coherence tomography evidence of retinal nerve fiber layer and ganglion cell loss in adult patients with neurofibromatosis type 1","volume":"36","author":"Abdolrahimzadeh","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2017.10.007_bib4","first-page":"851","article-title":"Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography","volume":"10","author":"Abdolrahimzadeh","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bjo.2006.109082","article-title":"Refractive errors in neurofibromatosis type 1 and type 2","volume":"91","author":"Akinci","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/ern.09.4","article-title":"Gliomas in patients with neurofibromatosis type 1","volume":"9","author":"Albers","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib7","first-page":"666","article-title":"Defining optic nerve tortuosity","volume":"28","author":"Armstrong","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/02688690310001601216","article-title":"Natural history and clinical management of optic pathway glioma","volume":"17","author":"Astrup","year":"2003","journal-title":"Br J Neurosurg"},{"issue":"21","key":"10.1016\/j.survophthal.2017.10.007_bib9","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","article-title":"Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group","volume":"30","author":"Ater","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ajo.2014.07.029","article-title":"Intra- and inter-visit reproducibility of ganglion cell-inner plexiform layer measurements using handheld optical coherence tomography in children with optic pathway gliomas","volume":"158","author":"Avery","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ajo.2013.01.011","article-title":"Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas","volume":"155","author":"Avery","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","article-title":"Optic pathway gliomas","volume":"31","author":"Avery","year":"2011","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","article-title":"Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ophtha.2016.09.020","article-title":"Orbital\/periorbital plexiform neurofibromas in children with neurofibromatosis type 1: multidisciplinary recommendations for care","volume":"124","author":"Avery","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajo.2010.08.046","article-title":"Retinal nerve fiber layer thickness in children with optic pathway gliomas","volume":"151","author":"Avery","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"24","key":"10.1016\/j.survophthal.2017.10.007_bib16","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1212\/WNL.0000000000002771","article-title":"Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1","volume":"86","author":"Avery","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0002-9394(00)00852-7","article-title":"Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging","volume":"131","author":"Balcer","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"4805","key":"10.1016\/j.survophthal.2017.10.007_bib18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.3107130","article-title":"Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17","volume":"236","author":"Barker","year":"1987","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0360-3016(91)90678-W","article-title":"Chiasmal gliomas: results of irradiation management in 57 patients and review of literature","volume":"21","author":"Bataini","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.survophthal.2017.10.007_bib20","first-page":"445","article-title":"Neurofibromatosis type 1 in children","volume":"93","author":"Beauchamp","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejpn.2015.12.002","article-title":"Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort","volume":"20","author":"Blanchard","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1","volume":"127A","author":"Blazo","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib23","first-page":"127","article-title":"Magnetic resonance imaging findings in children with spasmus nutans","volume":"21","author":"Bowen","year":"2017","journal-title":"J\u00a0AAPOS"},{"issue":"16","key":"10.1016\/j.survophthal.2017.10.007_bib24","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.3994-09.2010","article-title":"Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity","volume":"30","author":"Brown","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3928\/0191-3913-19910901-07","article-title":"Choroidal neurofibromatosis with congenital iris ectropion and buphthalmos: relationship and significance","volume":"28","author":"Burke","year":"1991","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/adc.79.4.334","article-title":"Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era","volume":"79","author":"Cappelli","year":"1998","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib27","first-page":"511","article-title":"Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas","volume":"14","author":"Chang","year":"2010","journal-title":"J\u00a0AAPOS"},{"issue":"877","key":"10.1016\/j.survophthal.2017.10.007_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1259\/bjr.74.877.740024","article-title":"MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis","volume":"74","author":"Chateil","year":"2001","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/eye.2011.336","article-title":"Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome","volume":"26","author":"Chaudhry","year":"2012","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/IOP.0b013e3181b8e4de","article-title":"Management of facial disfigurement in orbitotemporal neurofibromatosis","volume":"26","author":"Coban-Karatas","year":"2010","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib31","first-page":"99","article-title":"Visual-evoked responses in children with optic gliomas, with and without neurofibromatosis","volume":"10","author":"Cohen","year":"1983","journal-title":"Childs Brain"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng0995-90","article-title":"Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene","volume":"11","author":"Colman","year":"1995","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5435\/00124635-199907000-00002","article-title":"Neurofibromatosis in children: the role of the orthopaedist","volume":"7","author":"Crawford","year":"1999","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.survophthal.2017.10.007_bib34","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.7326\/0003-4819-61-6-1142","article-title":"Axillary freckling as a diagnostic aid in neurofibromatosis","volume":"61","author":"Crowe","year":"1964","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1953.00240180067008","article-title":"Diagnostic importance of cafe-au-lait spot in neurofibromatosis","volume":"91","author":"Crowe","year":"1953","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.survophthal.2017.10.007_bib36","series-title":"A\u00a0clinical, pathological and genetic study of multiple neurotibromatosis","author":"Crowe","year":"1956"},{"issue":"7","key":"10.1016\/j.survophthal.2017.10.007_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/08830738030180070401","article-title":"Optic pathway gliomas in children with and without neurofibromatosis 1","volume":"18","author":"Czyzyk","year":"2003","journal-title":"J\u00a0Child Neurol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9394(00)00454-2","article-title":"Surgical debulking of eyelid and anterior orbital plexiform neurofibromas by means of the carbon dioxide laser","volume":"130","author":"Dailey","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.10.007_bib39","first-page":"250","article-title":"Plexiform neurofibromatosis (von Recklinghausen's disease) of the orbit and globe, with associated glioma of the optic nerve and brain: report of a case","volume":"37","author":"Davis","year":"1939","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib40","first-page":"186","article-title":"Neurofibromatosis of the head and neck","volume":"14","author":"Davis","year":"1954","journal-title":"Plast Reconstr Surg (1946)"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0749.2004.00206.x","article-title":"Pigment cell-related manifestations in neurofibromatosis type 1: an overview","volume":"18","author":"De Schepper","year":"2005","journal-title":"Pigment Cell Res"},{"issue":"22","key":"10.1016\/j.survophthal.2017.10.007_bib42","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.88.22.9914","article-title":"Identification and characterization of the neurofibromatosis type 1 protein product","volume":"88","author":"DeClue","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib43","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1001\/archopht.1991.01080050076033","article-title":"Retinal manifestations of neurofibromatosis. Diagnosis and management","volume":"109","author":"Destro","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/088307389300800105","article-title":"Neurofibromatosis type 1: magnetic resonance imaging findings","volume":"8","author":"DiMario","year":"1993","journal-title":"J\u00a0Child Neurol"},{"issue":"26","key":"10.1016\/j.survophthal.2017.10.007_bib45","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib46","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0042-6989(95)00100-E","article-title":"Infrared imaging of sub-retinal structures in the human ocular fundus","volume":"36","author":"Elsner","year":"1996","journal-title":"Vis Res"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/01676830600987227","article-title":"Orbitotemporal neurofibromatosis: classification and treatment","volume":"26","author":"Erb","year":"2007","journal-title":"Orbit"},{"issue":"8","key":"10.1016\/j.survophthal.2017.10.007_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bjo.77.8.527","article-title":"Orbital plexiform neurofibroma","volume":"77","author":"Ferguson","year":"1993","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2013.6434","article-title":"Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1","volume":"150","author":"Ferrari","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.survophthal.2017.10.007_bib53","series-title":"Neurofibromatosis: phenotype, natural history, and pathogenesis","author":"Friedman","year":"1999"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2004-817697","article-title":"Reconstruction of sphenoid wing dysplasia with pulsating exophthalmos in a case of neurofibromatosis type 1 supported by intraoperative navigation using a new skull reference system","volume":"13","author":"Friedrich","year":"2003","journal-title":"Skull Base"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/ICU.0b013e32836348a4","article-title":"Treatment of neuro-ophthalmic and orbitofacial manifestations of neurofibromatosis type 1","volume":"24","author":"Gandhi","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib56","first-page":"297","article-title":"Myopia in neurofibromatosis type 1","volume":"32","author":"Garty","year":"1996","journal-title":"Isr J Med Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib57","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archderm.1993.01680240080011","article-title":"Phakomatosis pigmentovascularis type IIb with iris mammillations","volume":"129","author":"Gilliam","year":"1993","journal-title":"Arch Dermatol"},{"issue":"Pt 6","key":"10.1016\/j.survophthal.2017.10.007_bib58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/eye.2001.267","article-title":"Alveolar orbital rhabdomyosarcoma in a patient with neurofibromatosis type 1","volume":"15","author":"Glover","year":"2001","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s002340050734","article-title":"Spontaneous remission of chiasmatic\/hypothalamic masses in neurofibromatosis type 1: report of two cases","volume":"41","author":"Gottschalk","year":"1999","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00006534-198010000-00003","article-title":"Facial hamartomas in children: neurofibroma, lymphangioma, and hemangioma","volume":"66","author":"Grabb","year":"1980","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-8140(00)00149-3","article-title":"Radiation therapy of optico-hypothalamic gliomas (OHG)\u2013radiographic response, vision and late toxicity","volume":"54","author":"Grabenbauer","year":"2000","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archopht.1968.03850040129003","article-title":"Distinctive gonioscopic findings in glaucoma due to neurofibromatosis","volume":"79","author":"Grant","year":"1968","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib63","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0733-8635(18)30329-2","article-title":"Ocular and dermatologic manifestation of neurocutaneous syndromes","volume":"10","author":"Greenwald","year":"1992","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ceo.12179","article-title":"Long-term visual outcomes in patients with orbitotemporal neurofibromatosis","volume":"42","author":"Greenwell","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib65","first-page":"201","article-title":"Contribution of computerized tomography to the study of spheno-orbital dysplasia in neurofibromatosis","volume":"11","author":"Grenier","year":"1984","journal-title":"J\u00a0Neuroradiol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib66","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00006534-197206000-00012","article-title":"Von Recklinghausen's disease in children","volume":"49","author":"Griffith","year":"1972","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1531-8249(199903)45:3<393::AID-ANA17>3.0.CO;2-B","article-title":"Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma","volume":"45","author":"Grill","year":"1999","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib68","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1167\/iovs.13-13119","article-title":"Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas","volume":"55","author":"Gu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib69","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1215\/15228517-2006-030","article-title":"Temozolomide in children with progressive low-grade glioma","volume":"9","author":"Gururangan","year":"2007","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/13543784.2013.772979","article-title":"Optimizing biologically targeted clinical trials for neurofibromatosis","volume":"22","author":"Gutmann","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0896-6273(93)90324-K","article-title":"The neurofibromatosis type 1 gene and its protein product, neurofibromin","volume":"10","author":"Gutmann","year":"1993","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res"},{"issue":"41","key":"10.1016\/j.survophthal.2017.10.007_bib73","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1523\/JNEUROSCI.3242-12.2012","article-title":"Neurofibromatosis type 1: modeling CNS dysfunction","volume":"32","author":"Gutmann","year":"2012","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3476(95)70449-3","article-title":"Precocious puberty in children with neurofibromatosis type 1","volume":"126","author":"Habiby","year":"1995","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib75","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cc.3.10.1182","article-title":"Ras\/Raf\/ERK signalling and NF1","volume":"3","author":"Harrisingh","year":"2004","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib76","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1542\/peds.2007-3364","article-title":"Health supervision for children with neurofibromatosis","volume":"121","author":"Hersh","year":"2008","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.survophthal.2017.10.007_bib77","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.survophthal.2017.10.007_bib78","first-page":"E1","article-title":"Retinal vasoproliferative tumor in association with neurofibromatosis type 1","volume":"48","author":"Hood","year":"2009","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib79","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0360-3016(85)90052-5","article-title":"Optic gliomas: radiation therapy and prognosis","volume":"11","author":"Horwich","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib80","first-page":"604","article-title":"Surgical treatment of unilateral optic nerve gliomas","volume":"31","author":"Housepian","year":"1969","journal-title":"J\u00a0Neurosurg"},{"issue":"12","key":"10.1016\/j.survophthal.2017.10.007_bib81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/bjo.53.12.793","article-title":"Optic glioma of childhood. Natural history and rationale for conservative management","volume":"53","author":"Hoyt","year":"1969","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib82","first-page":"228","article-title":"Buphthalmos in neurofibromatosis: is it an expression of regional giantism?","volume":"14","author":"Hoyt","year":"1977","journal-title":"J\u00a0Pediatr Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.survophthal.2017.10.007_bib83","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales","volume":"111","author":"Huson","year":"1988","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib84","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1542\/peds.2011-3822","article-title":"Long-term differences in language and cognitive function after childhood exposure to anesthesia","volume":"130","author":"Ing","year":"2012","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib85","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0002-9394(14)76056-8","article-title":"Conjunctival hamartoma in neurofibromatosis","volume":"99","author":"Insler","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006534-199307000-00001","article-title":"Orbitotemporal neurofibromatosis: classification and treatment","volume":"92","author":"Jackson","year":"1993","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib87","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006534-198306000-00001","article-title":"The surgical management of orbital neurofibromatosis","volume":"71","author":"Jackson","year":"1983","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib88","first-page":"644","article-title":"Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1","volume":"23","author":"Jacquemin","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.survophthal.2017.10.007_bib89","first-page":"1678","article-title":"Orbit deformities in craniofacial neurofibromatosis type 1","volume":"24","author":"Jacquemin","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib90","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/pbc.20655","article-title":"Optic pathway gliomas","volume":"46","author":"Jahraus","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib91","first-page":"289","article-title":"Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas","volume":"19","author":"Jakacki","year":"2017","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib92","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00041327-200312000-00008","article-title":"Retinal vascular abnormalities in neurofibromatosis type 1","volume":"23","author":"Karadimas","year":"2003","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib93","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/neuonc\/nou329","article-title":"Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth","volume":"17","author":"Kaul","year":"2015","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib94","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bjps.2016.10.015","article-title":"A\u00a0combined one-stage surgical approach of orbital tumor debulking, lid reconstruction, and ptosis repair in children with orbitotemporal neurofibromatosis","volume":"70","author":"Keren","year":"2017","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib95","first-page":"32","article-title":"Moyamoya phenomenon after radiation for optic glioma","volume":"79","author":"Kestle","year":"1993","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.a.20211","article-title":"Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome","volume":"122A","author":"King","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib97","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib98","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-9394(85)90376-9","article-title":"Neurofibromatosis of the choroid","volume":"99","author":"Klein","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib99","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0039-6257(79)90147-4","article-title":"Ocular and orbital manifestations of neurofibromatosis","volume":"24","author":"Kobrin","year":"1979","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W","article-title":"Plexiform neurofibromas","volume":"89","author":"Korf","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.survophthal.2017.10.007_bib101","series-title":"Neurofibromatosis type 1: Molecular and cellular biology","first-page":"625","article-title":"Translational\/clinical studies in children and adults with neurofibromatosis type 1","author":"Korf","year":"2012"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib102","first-page":"1963","article-title":"Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis","volume":"22","author":"Kornreich","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib103","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0360-3016(90)90418-J","article-title":"Radiation therapy for gliomas of the optic nerve and chiasm","volume":"18","author":"Kovalic","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib104","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00043426-200305000-00005","article-title":"Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas","volume":"25","author":"Kuo","year":"2003","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"11","key":"10.1016\/j.survophthal.2017.10.007_bib105","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/sj.bjc.6601410","article-title":"Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy","volume":"89","author":"Lacaze","year":"2003","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.survophthal.2017.10.007_bib106","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/cncr.21091","article-title":"Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction","volume":"103","author":"Lafay-Cousin","year":"2005","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.survophthal.2017.10.007_bib107","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1200\/JCO.2003.03.043","article-title":"Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy\u2013results of the first French prospective study for the French Society of Pediatric Oncology","volume":"21","author":"Laithier","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib108","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of neurofibromatosis 1 in German children at elementary school enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib109","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0161-6420(84)34269-5","article-title":"Acquired nystagmus in early childhood: a presenting sign of intracranial tumor","volume":"91","author":"Lavery","year":"1984","journal-title":"Ophthalmology"},{"issue":"21","key":"10.1016\/j.survophthal.2017.10.007_bib110","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM199411243312102","article-title":"Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father","volume":"331","author":"Lazaro","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib111","first-page":"20","article-title":"Precise localization of NF1 to 17q11.2 by balanced translocation","volume":"44","author":"Ledbetter","year":"1989","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib112","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/FOC-07\/11\/E1","article-title":"Neuroophthalmological management of optic pathway gliomas","volume":"23","author":"Lee","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib113","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2003.05.029","article-title":"Orbitotemporal neurofibromatosis. Clinical features and surgical management","volume":"111","author":"Lee","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib114","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0007-1226(03)00172-3","article-title":"The surgical management of childhood orbito-temporal neurofibromatosis","volume":"56","author":"Lee","year":"2003","journal-title":"Br J Plast Surg"},{"issue":"8","key":"10.1016\/j.survophthal.2017.10.007_bib115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1212\/01.wnl.0000240076.31298.47","article-title":"The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1","volume":"67","author":"Leonard","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib116","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bjophthalmol-2015-306958","article-title":"Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening","volume":"100","author":"Levin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2017.10.007_bib117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0161-6420(84)34217-8","article-title":"von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata","volume":"91","author":"Lewis","year":"1984","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib118","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(81)35034-9","article-title":"Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata","volume":"88","author":"Lewis","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2017.10.007_bib119","first-page":"137","article-title":"Ueber Beteiligung der Augen, insbenson dere das Vorkommen von irisknotchen der Neurofibrmatose (Recklinghausen)","volume":"93","author":"Lisch","year":"1937","journal-title":"Z\u00a0Augenheilkd"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-3476(05)81151-5","article-title":"Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results","volume":"121","author":"Listernick","year":"1992","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib121","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","article-title":"Optic gliomas in children with neurofibromatosis type 1","volume":"114","author":"Listernick","year":"1989","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib123","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1096-8628(20010722)102:1<105::AID-AJMG1395>3.0.CO;2-C","article-title":"Comments on neurofibromatosis 1 and optic pathway tumors","volume":"102","author":"Listernick","year":"2001","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib124","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1023\/A:1006338322266","article-title":"Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type-1","volume":"45","author":"Listernick","year":"1999","journal-title":"J\u00a0Neurooncol"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib125","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","article-title":"Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history","volume":"127","author":"Listernick","year":"1995","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib127","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000144341.16830.01","article-title":"Late-onset optic pathway tumors in children with neurofibromatosis 1","volume":"63","author":"Listernick","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/01.icu.0000243016.90004.12","article-title":"Optic gliomas of the anterior visual pathway","volume":"17","author":"Liu","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2003.09.055","article-title":"Optic radiation involvement in optic pathway gliomas in neurofibromatosis","volume":"137","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9394(14)73984-4","article-title":"Spontaneous visual improvement in chiasmal gliomas","volume":"114","author":"Liu","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib132","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0887-8994(94)00110-N","article-title":"Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials","volume":"12","author":"Liu","year":"1995","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib133","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaad.2016.12.012","article-title":"The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: a retrospective case-control study","volume":"76","author":"Liy-Wong","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib134","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.clineuro.2010.07.007","article-title":"Reconstruction of skull base defects in sphenoid wing dysplasia associated with neurofibromatosis I with titanium mesh","volume":"112","author":"Lotfy","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"18","key":"10.1016\/j.survophthal.2017.10.007_bib135","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199105023241807","article-title":"Lisch nodules in neurofibromatosis type 1","volume":"324","author":"Lubs","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib136","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0733-8619(01)00019-6","article-title":"Neurofibromatosis 1","volume":"20","author":"Lynch","year":"2002","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1227\/00006123-199507000-00020","article-title":"Absence of the greater sphenoid wing in neurofibromatosis type I: congenital or acquired: case report","volume":"37","author":"Macfarlane","year":"1995","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib138","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/IOP.0b013e31805593f1","article-title":"A\u00a0novel approach to the management of severe facial disfigurement in neurofibromatosis type 1","volume":"23","author":"Madill","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib139","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/neuonc\/2.4.213","article-title":"Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study","volume":"2","author":"Mahoney","year":"2000","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.survophthal.2017.10.007_bib140","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bjps.2005.04.019","article-title":"Remodelling the upper eyelid in the management of orbitopalpebral neurofibromatosis","volume":"58","author":"Marchac","year":"2005","journal-title":"Br J Plast Surg"},{"issue":"20","key":"10.1016\/j.survophthal.2017.10.007_bib141","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1200\/JCO.2002.08.087","article-title":"High response rate to cisplatin\/etoposide regimen in childhood low-grade glioma","volume":"20","author":"Massimino","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib142","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0161-6420(97)30205-X","article-title":"Evidence of optic pathway gliomas after previously negative neuroimaging","volume":"104","author":"Massry","year":"1997","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib143","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00330-004-2433-y","article-title":"Pediatric brain MRI in neurofibromatosis type I","volume":"15","author":"Mentzel","year":"2005","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib144","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of\u00a0unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.survophthal.2017.10.007_bib145","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ophtha.2009.06.019","article-title":"Glaucoma and globe enlargement associated with neurofibromatosis type 1","volume":"116","author":"Morales","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib146","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002341-198804040-00002","article-title":"The surgical management of orbitopalpebral neurofibromatosis","volume":"4","author":"Morax","year":"1988","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.survophthal.2017.10.007_bib147","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.ejca.2010.03.028","article-title":"Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence","volume":"46","author":"Moreno","year":"2010","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1016\/j.survophthal.2017.10.007_bib148","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1177\/0883073816664659","article-title":"Macrocephaly is not a predictor of optic pathway glioma development or treatment in neurofibromatosis type 1","volume":"31","author":"Morris","year":"2016","journal-title":"J\u00a0Child Neurol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib149","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjo.86.3.282","article-title":"Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases","volume":"86","author":"Muci-Mendoza","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00006534-197402000-00010","article-title":"Giant neurofibroma of the head and neck","volume":"53","author":"Mukherji","year":"1974","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib151","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00417-005-1184-z","article-title":"Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis","volume":"243","author":"Nakakura","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.10.007_bib152","series-title":"Radiology of the skull and brain","author":"Newton","year":"1971"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib153","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0887-8994(00)00230-7","article-title":"Visual-evoked potentials in the assessment of optic gliomas","volume":"24","author":"Ng","year":"2001","journal-title":"Pediatr Neurol"},{"issue":"7","key":"10.1016\/j.survophthal.2017.10.007_bib154","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/pbc.22198","article-title":"Natural history and outcome of optic pathway gliomas in children","volume":"53","author":"Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.survophthal.2017.10.007_bib155","series-title":"Neurofibromatosis type 1 in childhood","author":"North","year":"1997"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib156","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/088307389300800421","article-title":"Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic","volume":"8","author":"North","year":"1993","journal-title":"J\u00a0Child Neurol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib157","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0887-8994(94)90043-4","article-title":"Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials","volume":"10","author":"North","year":"1994","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib158","first-page":"717","article-title":"The diagnosis of neurofibromatosis-1 in the child under the age of 6 years","volume":"143","author":"Obringer","year":"1989","journal-title":"Am J Dis Child"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib159","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0887-8994(85)90036-0","article-title":"The moyamoya syndrome associated with irradiation of an optic glioma in children: report of two cases and review of the literature","volume":"1","author":"Okuno","year":"1985","journal-title":"Pediatr Neurol"},{"issue":"12","key":"10.1016\/j.survophthal.2017.10.007_bib160","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ejca.2006.02.022","article-title":"Prognostic factors for progression of childhood optic pathway glioma: a systematic review","volume":"42","author":"Opocher","year":"2006","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib161","first-page":"232","article-title":"Lisch nodules and skin manifestation in neurofibromatosis type 1","volume":"137","author":"Otsuka","year":"2001","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib162","first-page":"338","article-title":"Ocular motility abnormalities in orbitofacial neurofibromatosis type 1","volume":"18","author":"Oystreck","year":"2014","journal-title":"J\u00a0AAPOS"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib163","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.ophtha.2012.04.032","article-title":"Visual loss in orbitofacial neurofibromatosis type 1","volume":"119","author":"Oystreck","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib164","first-page":"747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"Packer","year":"1997","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib165","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","article-title":"Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood","volume":"11","author":"Packer","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib166","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00006534-200204010-00002","article-title":"Netting operation to control neurofibroma of the face","volume":"109","author":"Park","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib167","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3928\/01913913-20160810-03","article-title":"Optic gliomas in neurofibromatosis type 1","volume":"53","author":"Parkhurst","year":"2016","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"13","key":"10.1016\/j.survophthal.2017.10.007_bib168","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1167\/iovs.13-13093","article-title":"Optical coherence tomography in the diagnosis of optic pathway gliomas","volume":"54","author":"Parrozzani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2017.10.007_bib169","article-title":"Retinal vascular abnormalities in a large cohort of patients affected by neurofibromatosis type 1: a study using optical coherence tomography angiography","author":"Parrozzani","year":"2017","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/archopht.119.4.516","article-title":"Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging","volume":"119","author":"Parsa","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib171","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00381-006-0061-3","article-title":"Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature","volume":"22","author":"Piccirilli","year":"2006","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib172","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/1097-0142(19900101)65:1<45::AID-CNCR2820650111>3.0.CO;2-Z","article-title":"Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects","volume":"65","author":"Pierce","year":"1990","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib173","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","article-title":"The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1","volume":"167","author":"Prada","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.survophthal.2017.10.007_bib174","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1167\/iovs.04-0080","article-title":"Recovery from form-deprivation myopia in rhesus monkeys","volume":"45","author":"Qiao-Grider","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00061198-200404000-00002","article-title":"Gonioscopic findings in patients with type 1 neurofibromatosis (Von Recklinghausen disease)","volume":"13","author":"Quaranta","year":"2004","journal-title":"J\u00a0Glaucoma"},{"issue":"Pt 1","key":"10.1016\/j.survophthal.2017.10.007_bib176","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/eye.1996.13","article-title":"Iris mammillations: significance and associations","volume":"10","author":"Ragge","year":"1996","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.survophthal.2017.10.007_bib177","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1414786","article-title":"Anesthetic neurotoxicity\u2013clinical implications of animal models","volume":"372","author":"Rappaport","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib178","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib179","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000027287","article-title":"Clinical application of digital indocyanine green angiography in choroidal neurofibromatosis","volume":"212","author":"Rescaldani","year":"1998","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib180","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0161-6420(84)34288-9","article-title":"Congenital ectropion uveae with glaucoma","volume":"91","author":"Ritch","year":"1984","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2017.10.007_bib181","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.survophthal.2017.10.007_bib182","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.56.7.827","article-title":"Why do benign astrocytomas become malignant in NF1?","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.survophthal.2017.10.007_bib183","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/bjo.2004.043802","article-title":"Ophthalmological manifestations in segmental neurofibromatosis type 1","volume":"88","author":"Ruggieri","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib184","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08820530701745223","article-title":"Neurofibromatosis type I: genetics and clinical manifestations","volume":"23","author":"Savar","year":"2008","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib185","first-page":"155","article-title":"Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients","volume":"14","author":"Segal","year":"2010","journal-title":"J\u00a0AAPOS"},{"issue":"11","key":"10.1016\/j.survophthal.2017.10.007_bib186","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/088307380001501112","article-title":"Moyamoya syndrome after radiation therapy for optic pathway glioma: case report","volume":"15","author":"Serdaroglu","year":"2000","journal-title":"J\u00a0Child Neurol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.23143","article-title":"Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1","volume":"57","author":"Shaikh","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.survophthal.2017.10.007_bib188","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib189","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.icu.0000158258.01681.40","article-title":"Review of optical coherence tomography for intraocular tumors","volume":"16","author":"Shields","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib190","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamaophthalmol.2013.6281","article-title":"Retinal vasoproliferative tumors in 6 patients with neurofibromatosis type 1","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib191","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.22967","article-title":"Visual outcome following chemotherapy for progressive optic pathway gliomas","volume":"57","author":"Shofty","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib192","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IOP.0b013e318032af94","article-title":"Orbital embryonal rhabdomyosarcoma in association with neurofibromatosis type 1","volume":"23","author":"Shome","year":"2007","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib193","first-page":"184","article-title":"Combined transcranial-orbital approach for resection of optic nerve gliomas: a clinical and anatomical study","volume":"28","author":"Shriver","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib194","first-page":"293","article-title":"VEP testing and visual pathway gliomas: not quite ready for prime time","volume":"10","author":"Siatkowski","year":"2006","journal-title":"J\u00a0AAPOS"},{"issue":"11","key":"10.1016\/j.survophthal.2017.10.007_bib195","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1177\/0883073809342005","article-title":"Pediatric low-grade gliomas","volume":"24","author":"Sievert","year":"2009","journal-title":"J\u00a0Child Neurol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib196","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1096-8628(20000814)93:4<269::AID-AJMG3>3.0.CO;2-Y","article-title":"Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1)","volume":"93","author":"Sigorini","year":"2000","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib197","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/adc.87.1.65","article-title":"Neurofibromatosis type 1 and sporadic optic gliomas","volume":"87","author":"Singhal","year":"2002","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib198","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SCS.0b013e318270fadd","article-title":"Soft tissue management of orbitotemporal neurofibromatosis","volume":"24","author":"Singhal","year":"2013","journal-title":"J\u00a0Craniofac Surg"},{"key":"10.1016\/j.survophthal.2017.10.007_bib199","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003086-198908000-00002","article-title":"A\u00a0treatise on the pathology, diagnosis and treatment of neuroma. 1849","volume":"245","author":"Smith","year":"1989","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib200","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced depth imaging spectral-domain optical coherence tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2017.10.007_bib201","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.ophtha.2004.03.031","article-title":"Swedish interactive thresholding algorithm fast for following visual fields in prepubertal idiopathic intracranial hypertension","volume":"111","author":"Stiebel-Kalish","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib202","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jpeds.2004.02.026","article-title":"Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV","volume":"144","author":"Sung","year":"2004","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib203","first-page":"583","article-title":"Long-term outcome of hypothalamic\/chiasmatic astrocytomas in children treated with conservative surgery","volume":"83","author":"Sutton","year":"1995","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.icu.0000193070.32369.37","article-title":"Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1","volume":"17","author":"Sylvester","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N","article-title":"Associations of clinical features in neurofibromatosis 1 (NF1)","volume":"19","author":"Szudek","year":"2000","journal-title":"Genet Epidemiol"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib206","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","article-title":"Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients","volume":"111","author":"Thiagalingam","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib207","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.ejhg.5200493","article-title":"Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene","volume":"8","author":"Tinschert","year":"2000","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib208","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0039-6257(89)90014-3","article-title":"Neurofibromatosis and neural crest neoplasms: primary acquired melanosis and malignant melanoma of the conjunctiva","volume":"33","author":"To","year":"1989","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib209","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s10384-014-0308-6","article-title":"Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1","volume":"58","author":"Topcu-Yilmaz","year":"2014","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","article-title":"Neurofibromin: a general outlook","volume":"70","author":"Trovo-Marqui","year":"2006","journal-title":"Clin Genet"},{"issue":"12","key":"10.1016\/j.survophthal.2017.10.007_bib211","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1212\/01.wnl.0000257095.33125.48","article-title":"Moyamoya following cranial irradiation for primary brain tumors in children","volume":"68","author":"Ullrich","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib212","first-page":"88","article-title":"Optic nerve sheath fenestration for an isolated optic nerve glioma","volume":"13","author":"Vanderveen","year":"2009","journal-title":"J\u00a0AAPOS"},{"issue":"2","key":"10.1016\/j.survophthal.2017.10.007_bib213","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2011.07.046","article-title":"Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1","volume":"119","author":"Viola","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2017.10.007_bib214","article-title":"Duane's clinical ophthalmology","volume":"Vol 5","author":"Vivian","year":"2013"},{"key":"10.1016\/j.survophthal.2017.10.007_bib215","series-title":"Ber die Multiplen Fibrome der Haut und Ihre Beziehung zu den Multiplen Neuromen","author":"Von Recklinghausen","year":"1882"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib216","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/neuonc\/nou235","article-title":"Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study","volume":"17","author":"Weiss","year":"2015","journal-title":"Neuro Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib217","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11912-009-0045-z","article-title":"Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"11","author":"Widemann","year":"2009","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"10.1016\/j.survophthal.2017.10.007_bib218","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/pbc.25041","article-title":"Phase II trial of pirfenidone in children and young adults\u00a0with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"61","author":"Widemann","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.survophthal.2017.10.007_bib219","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/neuonc\/nou004","article-title":"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"16","author":"Widemann","year":"2014","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib221","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/13816819109023079","article-title":"Structure of Lisch nodules in neurofibromatosis type 1","volume":"12","author":"Williamson","year":"1991","journal-title":"Ophthalmic Paediatr Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib222","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3928\/0191-3913-19900101-13","article-title":"Congenital iris ectropion and a new classification for anterior segment dysgenesis","volume":"27","author":"Wilson","year":"1990","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"10.1016\/j.survophthal.2017.10.007_bib223","first-page":"307","article-title":"Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?","volume":"10","author":"Wolsey","year":"2006","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.survophthal.2017.10.007_bib224","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0002-9394(62)93279-8","article-title":"Neuro-fibromatosis of the choroid","volume":"54","author":"Wolter","year":"1962","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02307012","article-title":"Choroidal ganglioneuroma in neurofibromatosis","volume":"220","author":"Woog","year":"1983","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2017.10.007_bib226","series-title":"Pediatric ophthalmology and\u00a0strabismus","first-page":"766","author":"Wright","year":"2003"},{"issue":"3","key":"10.1016\/j.survophthal.2017.10.007_bib227","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"9234","key":"10.1016\/j.survophthal.2017.10.007_bib228","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(00)02716-1","article-title":"Frequency of choroidal abnormalities in neurofibromatosis type 1","volume":"356","author":"Yasunari","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib229","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00043426-200108000-00005","article-title":"Weekly dosing of carboplatin increases risk of allergy in children","volume":"23","author":"Yu","year":"2001","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.survophthal.2017.10.007_bib230","first-page":"534","article-title":"Orbital optic nerve gliomas in children with neurofibromatosis type 1","volume":"10","author":"Zeid","year":"2006","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.survophthal.2017.10.007_bib231","first-page":"e49","article-title":"Childhood orbitotemporal neurofibromatosis masked by congenital glaucoma and buphthalmos","volume":"48 Online","author":"Ziakas","year":"2011","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"10.1016\/j.survophthal.2017.10.007_bib232","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1148\/radiology.146.1.6401362","article-title":"Computed tomography of orbitalfacial neurofibromatosis","volume":"146","author":"Zimmerman","year":"1983","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.survophthal.2017.10.007_bib233","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archderm.1995.01690200040007","article-title":"Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis","volume":"131","author":"Zvulunov","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2017.10.007_bib234","unstructured":"https:\/\/www.uab.edu\/nfconsortium\/."}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625717301261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625717301261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:46:28Z","timestamp":1758541588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625717301261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":234,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0039625717301261"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2017.10.007","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmic manifestations in neurofibromatosis type 1","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}